insights_auto
Why is GANX down 6.31%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
US$1.04
arrow_downward
-6.31%(-0.070) 1D
ኖቬም 19, 3:30:03 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
US$1.12
High
US$1.14
Low
US$1.03
Mkt. cap
46.31 ሚ
Avg. vol.
684.23 ሺ
Volume
470.05 ሺ
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
Open
US$1.12
High
US$1.14
Low
US$1.03
Mkt. cap
46.31 ሚ
Avg. vol.
684.23 ሺ
Volume
470.05 ሺ
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
News stories
From web sources and news partners
Quantisnow
·
ከ1 ቀን በፊት
GANX: Gain Therapeutics Inc. filed SEC Form 8-K: Other Events
Investing.com
·
ከ1 ቀን በፊት
Gain Therapeutics reports 12-month rexaceract trial results
Benzinga
·
ከ2 ቀናት በፊት
12 Health Care Stocks Moving In Tuesday's Intraday Session
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com